Jump to content

Kirsten Bibbins-Domingo

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by BD2412 (talk | contribs) at 02:39, 23 October 2022 (→Career: Clean up spacing errors around ref tags., replaced: /ref>a → /ref> a). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Kirsten Bibbins-Domingo in 2021

Kirsten Bibbins-Domingo is an American epidemiologist and physician. She is the 17th Editor in Chief of the Journal of the American Medical Association (JAMA) and the JAMA Network.[1] She is Professor of Epidemiology and Biostatistics and the Lee Goldman, MD Endowed Professor of Medicine at University of California, San Francisco.[2] She is a general internist and attending physician at San Francisco General Hospital.

Bibbins-Domingo is a recognized expert in prevention and health equity and has published more than 200 peer-reviewed original research articles.[3] She is a cardiovascular disease epidemiologist whose work focuses on clinical and public health approaches to prevention, particularly in young adults.[4] She served as the chair, vice-chair, and member of the United States Preventive Services Task Force from 2010-2017.

At UCSF she served as the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine, and was the Chair of the UCSF Department of Epidemiology and Biostatistics from 2017-2022.[5] In 2006, Bibbins-Domingo co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on advancing health equity and reducing health disparities in the San Francisco Bay Area, nationally, and globally.

Kirsten Bibbins-Domingo at UCSF Parnassus

Bibbins-Domingo was a trustee of Princeton University from 2018-2022.[6]

Early life and college

Kirsten Bibbins-Domingo was born in Stuttgart, Germany[7] while her father was stationed in the country. Bibbins-Domingo attended Eleanor Roosevelt, a public science tech high school in Maryland.

She graduated from Princeton University in 1987 with a degree in molecular biology and the Princeton School of Public and International Affairs.[8] She then received a PhD in biochemistry, an MD, and a Masters in Clinical Research from the University of California, San Francisco as part of the Medical Scientist Training Program. Bibbins-Domingo also studied chemistry[5] at the University of Ibadan.[5]

Career

Bibbins-Domingo is an NIH funded investigator who uses observational studies, simulation models, and pragmatic trials to understand the development of cardiovascular risk and examine the impact of clinical and public health approaches to cardiovascular disease prevention.[9]

Her work published in the New England Journal of Medicine highlighted the high rate of incident heart failure among African American men and women before age 50[10] She has also published on the impact or adolescent obesity on future rates of cardiovascular disease in young adults.[11] She has led two NIH center grants focused on disparities in diabetes, cardiovascular disease, and stroke in young adulthood.[12]

Her work has examined the population health impact of policy approaches to reduce consumption of salt [13] and sugary beverages. [14] in the US and in other countries.[15] These publications helped inform policy changes and public health interventions, including taxation of sugary beverages and interventions aimed at population-wide reductions in dietary sodium.

Bibbins-Domingo published a series of cost-effectiveness analyses on the PCSK-9 inhibitor medications in JAMA and Annals of Internal Medicine.[16][17]

In 2016, she was named chair of the U.S. Preventive Services Task Force and led the US Preventive Services Task Force during several high profile recommendations on breast cancer, colon cancer, and prostate cancer.[18] six years after she became a member of the task force.[5] In 2017, the U.S. Preventive Services Task Force changed their recommendation on PSA testing for prostate cancer[19] and Bibbins-Domingo appeared on PBS in 2017 to describe this decision.[20]

Honors and awards

Bibbins-Domingo is an inducted member of the American Society for Clinical Investigation, the Association of American Physicians, and the National Academy of Medicine.[9]

In 2017, Bibbins-Domingo received the UCSF Chancellor’s Award for Public Service.[21] In the same year she was selected to deliver the Ancel Keyes Lecture by the American Heart Association Epidemiology Council.

Bibbins-Domingo has received mentoring awards from the Society of General Internal Medicine and UCSF Phillip R. Lee Institute for Health Policy Studies.

While at Princeton, Bibbins-Domingo received the Moses Taylor Pyne Prize as a senior.[9]

Personal life

Bibbins-Domingo's son, Stephen played college basketball for Georgetown[22] and the University of California, Berkeley. He graduated from the Haas School of Business in 2017 and has played professional basketball in the Dutch Basketball League.[23] He is currently a small forward for the Lakeland Magic. Kirsten Bibbins-Domingo is married to Patrick Domingo.[22]

Works

  • Disease Prevention, An Issue of Medical Clinics of North America, The Clinics Internal Medicine series, co-authored with Michael P. Pignone MD, Elsevier, 2017, ISBN 978-0323531382

References

  1. ^ "Cardiovascular disease epidemiologist named JAMA's new top editor".
  2. ^ "Kirsten Bibbins-Domingo | UCSF Profiles". profiles.ucsf.edu. Retrieved 2018-08-09.
  3. ^ "Kirsten Bibbins-Domingo". Google Scholar.
  4. ^ "Kirsten Bibbins-Domingo | UCSF Profiles". profiles.ucsf.edu.
  5. ^ a b c d "Kirsten Bibbins-Domingo, PhD, MD, MAS Appointed as Chair of Epidemiology and Biostatistics and Inaugural Vice Dean for Population Health and Health Equity | UCSF School of Medicine". medschool.ucsf.edu. Retrieved 2018-08-09.
  6. ^ "Six elected to Princeton Board of Trustees". Princeton University.
  7. ^ "Kirsten Bibbins-Domingo". SF Build (San Francisco State University). San Francisco State University. Retrieved 6 October 2018.
  8. ^ "Six elected to Princeton Board of Trustees". Princeton University. Retrieved 2018-08-09.
  9. ^ a b c "Kirsten Bibbins-Domingo | UCSF Profiles". profiles.ucsf.edu.
  10. ^ Bibbins-Domingo, Kirsten; Pletcher, Mark J.; Lin, Feng; Vittinghoff, Eric; Gardin, Julius M.; Arynchyn, Alexander; Lewis, Cora E.; Williams, O. Dale; Hulley, Stephen B. (2009). "Racial Differences in Incident Heart Failure among Young Adults". New England Journal of Medicine. 360 (12): 1179–1190. doi:10.1056/NEJMoa0807265. PMC 2829671. PMID 19297571.
  11. ^ Bibbins-Domingo, Kirsten; Coxson, Pamela; Pletcher, Mark J.; Lightwood, James; Goldman, Lee (2007). "Adolescent Overweight and Future Adult Coronary Heart Disease". New England Journal of Medicine. 357 (23): 2371–2379. doi:10.1056/NEJMsa073166. PMID 18057339.
  12. ^ "High blood pressure among blacks and young adults is focus of $11 million stroke prevention project". Eureka Alert. Eureka Alert. Retrieved 9 August 2018.
  13. ^ Bibbins-Domingo, Kirsten; Chertow, Glenn M.; Coxson, Pamela G.; Moran, Andrew; Lightwood, James M.; Pletcher, Mark J.; Goldman, Lee (2010). "Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease". New England Journal of Medicine. 362 (7): 590–599. doi:10.1056/nejmoa0907355. PMC 3066566. PMID 20089957.
  14. ^ "How Many Lives Could a Soda Tax Save?". How Many Lives Could a Soda Tax Save? | UC San Francisco.
  15. ^ "Taxes trimmed Mexican soda consumption for two years". Reuters. March 1, 2017 – via www.reuters.com.
  16. ^ Kazi, D. S.; Moran, A. E.; Coxson, P. G.; Penko, J.; Ollendorf, D. A.; Pearson, S. D.; Tice, J. A.; Guzman, D.; Bibbins-Domingo, K. (2016). "Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients with Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease". JAMA. 316 (7): 743–53. doi:10.1001/jama.2016.11004. PMID 27533159.
  17. ^ Kazi, D. S.; Penko, J.; Coxson, P. G.; Moran, A. E.; Ollendorf, D. A.; Tice, J. A.; Bibbins-Domingo, K. (2017). "Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial". JAMA. 318 (8): 748–750. doi:10.1001/jama.2017.9924. PMC 5817484. PMID 28829863.
  18. ^ "Biography - US Preventive Services Task Force". www.uspreventiveservicestaskforce.org. Retrieved 2018-08-09.
  19. ^ "The federal panel that opposed prostate cancer screening just changed its mind". Washington Post. Retrieved 9 August 2018.
  20. ^ "Why this prostate cancer screening guideline just got reversed". PBS. PBS. 11 April 2017. Retrieved 9 August 2018.
  21. ^ "2017 Founders Day Awards Recognize Extraordinary Public Service, University Management". 2017 Founders Day Awards Recognize Extraordinary Public Service, University Management | UC San Francisco.
  22. ^ a b "Stephen Domingo". GU Hoyas. GU Hoyas. Retrieved 6 October 2018.
  23. ^ "Donar legt de Amerikaan Stephen Domingo voor een seizoen vast" (in Dutch). Donar.nl. 19 July 2017.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Kirsten_Bibbins-Domingo&oldid=1117692662"